Predictive value of modified frailty index-5 to major complications after videothoracoscopic pulmonary resections - Summary - MDSpire

Predictive value of modified frailty index-5 to major complications after videothoracoscopic pulmonary resections

  • By

  • Muhammet Sayan

  • Mahir Fattahov

  • Fevzi Oguzhan Temirkaynak

  • Nazmiye Koska

  • Bengisu Artiran

  • Muhammet Tarik Aslan

  • Gunel Ahmadova

  • Aysegul Kurtoglu

  • Irmak Akarsu

  • Ismail Cuneyt Kurul

  • Ali Celik

  • May 14, 2025

  • 0 min

Share

Objective:

To investigate the effect of modified frailty index-5 (MFI-5) in predicting postoperative complications, including 30-day mortality, in patients undergoing VATS lobectomy or segmentectomy specifically for NSCLC.

Key Findings:
  • MFI-5 includes hypertension, diabetes mellitus, chronic obstructive pulmonary disease, congestive heart failure, and functional independence status, with each component correlating to specific postoperative complications.
Interpretation:

The MFI-5 can serve as a useful tool for predicting major complications and mortality in patients undergoing VATS pulmonary resections.

Limitations:
  • Retrospective nature may introduce bias.
  • Limited generalizability due to single-center study design.
  • Potential confounding factors not accounted for in analysis.
  • Missing data may impact the reliability of findings.
Conclusion:

MFI-5 is a valuable predictor of postoperative complications in VATS lobectomy or segmentectomy for NSCLC, warranting its consideration in preoperative assessments to improve patient outcomes.

Original Source(s)

Predictive value of modified frailty index-5 to major complications after videothoracoscopic pulmonary resections

  • by Muhammet Sayan, Mahir Fattahov, Fevzi Oguzhan Temirkaynak, Nazmiye Koska, Bengisu Artiran, Muhammet Tarik Aslan, Gunel Ahmadova, Aysegul Kurtoglu, Irmak Akarsu, Ismail Cuneyt Kurul, Ali Celik

  • May 14, 2025

Related Content

Comparative Analysis of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Trials

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

AAE Revises Dental Trauma Guidance

Recommendations outline splinting, replantation timing, imaging, and long-term surveillance strategies for permanent tooth injuries.